Table 3 Differences in outcome between the PD-Lo and the PD-Hi patients at treatment termination (week 20) and three-month follow-up (week 32)
week 20 | week 32 | |||
|---|---|---|---|---|
Outcome measure | EMD (SE) | p | EMD (SE) | p |
SCL scales | ||||
anxiety | −0.61 (0,93) | .51 | −1.78 (1.02) | .08 |
phobic anxiety | −1.24 (0.54) | .02 | − 1.21 (0.59) | .04 |
depression | −5.12 (1.98) | .01 | −7.44 (2.09) | .00* |
somatisation | −0.86 (0.93) | .36 | −1.02 (1.03) | .32 |
insufficiency | 0.44 (0.84) | .60 | −0.66 (0.91) | .47 |
interpersonal sensitivity | −1.10 (1.45) | .45 | −3.53 (1.57) | .03 |
hostility | 0.61 (0.48) | .21 | 0.03 (0.53) | .96 |
sleep problems | 0.16 (0.39) | .69 | −0.38 (0.43) | .44 |
other | −0.67 (0.64) | .29 | −2.76 (0.69) | .00* |
General Symptom Inventory | −12.09 (6.64) | .07 | −23.61 (7.17) | .00* |
YSQ domains | ||||
schema severity | 0.02 (0.08) | .81 | 0.03 (0.09) | .72 |
disconnection-rejection | 0.05 (0.08) | .54 | 0.003 (0.10) | .98 |
impaired autonomy | −0.48 (0.08) | .56 | −0.0002 (0.09) | .99 |
impaired limits | 0.10 (0.07) | .19 | 0.12 (0.08) | .14 |
other directedness | 0.12 (0.10) | .19 | 0.10 (0.10) | .34 |
overvigilance and inhibition | −0.01 (0.08) | .95 | −0.04 (0.09) | .66 |
UCL scales | ||||
active coping | 0.49 (0.42) | .25 | 0.74 (0.47) | .11 |
avoidance | 0.26 (0.47) | .59 | 0.57 (0.52) | .27 |
palliative reaction pattern | −0.26 (0.52) | .96 | 0.77 (0.58) | .18 |
seeking social support | 0.25 (0.44) | .57 | 0.35 (0.48) | .47 |